In addition, we found that enhanced expression of FGFRL1 promoted ENO1 expression and its downstream PI3K/Akt pathway in SCLC cells, whereas decreased expression of FGFRL1 had the opposite effects. This evidence concerns the gene FGFRL1 and small cell lung carcinoma.